CALR and neoplasm: Supporting the activation of immunogenic apoptosis, we observed a significant increase in plasma HMGB1 levels (Fig. 5B) and enhanced exposure of calreticulin on the surface of B16F10 tumor cells (Fig. 5A, 5th column).